Alexey A. Matskevich
Hoofd Techniek/Wetenschap/O&O bij TheraMAB LLC
Profiel
Alexey A.
Matskevich is currently the Chief Scientific Officer at TheraMAB LLC.
Prior to this, he worked as a Senior Research Associate at the University of Zurich, the University of Lausanne, and the University of Strasbourg.
He received his graduate and doctorate degrees from Moscow State University Lomonosov.
Actieve functies van Alexey A. Matskevich
| Bedrijven | Functie | Begin |
|---|---|---|
TheraMAB LLC
 TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Alexey A. Matskevich
| Bedrijven | Functie | Einde |
|---|---|---|
| University of Lausanne | Corporate Officer/Principal | 01-01-2009 |
| University of Zurich | Corporate Officer/Principal | 01-01-2008 |
| University of Strasbourg | Corporate Officer/Principal | 01-01-2005 |
Opleiding van Alexey A. Matskevich
| Moscow State University Lomonosov | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
TheraMAB LLC
TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Health Technology |
